Firibastat in Treatment-resistant Hypertension

NCT04277884 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

515

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Firibastat
DRUG: Placebo

Sponsor

Quantum Genomics SA